Cholestasis-induced fibrosis is reduced by interferon α-2a and is associated with elevated liver metalloprotease activity

Journal of Hepatology

Volumn 33, Issue 6, 2000, Pages 915-925

  Bueno, Miriam R ^a   Daneri, Adrian ^a   Armendáriz Borunda, Juan ^a  

^a UNIVERSITY OF GUADALAJARA   (Mexico)

Author keywords

Bile duct ligation; Cholestasis; Cirrhosis; Collagen; Interferon; Metalloproteases

Indexed keywords

ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; ALPHA2A INTERFERON; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; GELATIN; METALLOPROTEINASE; TISSUE INHIBITOR OF METALLOPROTEINASE 1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BILIRUBIN BLOOD LEVEL; CHOLESTASIS; CONTROLLED STUDY; DOWN REGULATION; DRUG DISTRIBUTION; DRUG EFFICACY; DRUG MECHANISM; DRUG SCREENING; ENZYME ACTIVITY; ENZYME BLOOD LEVEL; FIBROSIS; GENE EXPRESSION; HISTOLOGY; IMMUNOREACTIVITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; ZYMOGRAPHY;

EID: 0033652197     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8278(00)80123-3     Document Type: Article

References (41)

1. Evaluation of colchicine therapy in primary biliar cirrhosis
2. Double blind controlled trial of D-penicillamine in patients with primary biliary cirrhosis
3. Perspectives in the treatment of liver fibrosis
4. Recombinant interferon alpha therapy for chronic hepatitis C: A randomized, double-blind, placebo-controlled trial
5. Randomized trial of lymphoblastoid alpha interferon in chronic hepatitis C. Effects on inflammation fibrogenesis and viremia
6. Histological autocome in interferon alpha-2b treated patients with chronic post-tranfusion non-A non-B hepatitis
7. Interferon-a(2b) increases fibrolysis in fibrotic livers from bile duct ligated rats: Possible participation of the plasminogen activator
8. Transcriptional control of matrix metalloproteinases and the tissue inhibitors of matrix metalloproteinases
9. Extracellular matrix degradation
10. Matrix turnover in fibrogenesis
11. Collagenases and liver fibrosis
12. The significance of colocalization of plasminogen activator inhibitor α-1 and vitronectin in hepatic fibrosis
13. Production of tissue-type plasminogen activator (t-PA) and type-1 plasminogen activator inhibitor (PAI-1) in mildly cirrhotic rat liver
14. Modeling the impact of interferon alfa treatment on liver fibrosis progression in chronic hepatitis C: A dynamic view. The Multiviric Group
15. Regression of hepatic fibrosis C with long-term interferon treatment
16. Hemodynamic characterization of chronic bile duct-ligated rats: Effect of pentobarbital sodium
17. Alpha-interferon prevents liver collagen deposition and damage induced by prolonged bile duct obstruction in the rat
18. Gamma-interferon inhibits secretin-induced choleresis and cholangiocyte proliferation in a murine model of cirrhosis
19. Regulation of TGFb gene expression in rat liver intoxicated with carbon tetrachloride
20. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding
21. Proteolytic activity in extracts of invasive cervical carcinoma and precursor lesions
22. Increased expression of matrix metalloproteinase-II in experimental liver fibrosis in rats
23. Catalytic classes of proteinases of Entamoeba histolytica
24. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol chloroform extraction
25. Treatment with anti-transforming growth factor b antibodies influences an altered pattern of cytokines expression in injured rat liver
26. A simple micromethod for collagen and total protein determination in formalin-fixed paraffin-embedded sections
27. Histopathological evaluation of liver fibrosis: Quantitative imagen analysis vs semi-quantitative scores
28. Urokinase-type plasminogen activator and plasminogen activator inhibitors (PAI-1 and PAI-2) in extracts of invasive cervical carcinoma and precursor lesions
29. Expression of metalloproteinase that degrades native type V collagen and denatured collagens by cultured human alveolar macrophages
30. Presence of gelatin-specific proteinase and its latent form in human leukocytes
31. Biochemical and immunological characterization of secreted forms of human neutrophil gelatinase
32. Lipocytes from normal rat liver release a neutral metalloproteinase that degrades basement membrane (type IV) collagen
33. Kupffer cell-derived 95-Kd type IV collagenase/gelatinase B: Characterization and expression in cultured cells
34. Remodeling of human myocardial collagen in idiophathic dilated cardiomyopathy
35. Extracellular matrix deposition, lysyl oxidase expression, and myofibroblastic differentiation during the initial stages of cholestatic fibrosis in rat
36. Expression patterns of matrix metalloproteinases and their inhibitors in parenchymal and non-parenchymal cells of rat liver: Regulation by TNF alpha and TGFβ1
37. Bleomycin-induced pulmonary fibrosis in transgenic mice that either lack or overexpress the murine plasminogen activator inhibitor-1 gene
38. TIMP expression in toxic and cholestatic liver in rat
39. Circulating matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-1 as serum markers of fibrosis in patients with chronic hepatitis C. Relationship to interferon response
40. Cytokine regulation of the matrix metalloproteinases and their inhibitors in human papillomavirus-18 transformed human prostatic tumor cell lines